Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

625 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RUNX1 gene alterations characterized by allelic preference in adult acute myeloid leukemia.
Cumbo C, Tota G, De Grassi A, Anelli L, Zagaria A, Coccaro N, Tarantini F, Minervini CF, Parciante E, Impera L, Conserva MR, Redavid I, Mestice A, Attolico I, Pierri CL, Musto P, Albano F. Cumbo C, et al. Among authors: musto p. Leuk Lymphoma. 2023 Mar;64(3):717-721. doi: 10.1080/10428194.2021.1929960. Epub 2021 May 24. Leuk Lymphoma. 2023. PMID: 34027815 No abstract available.
Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors.
Russo Rossi A, Breccia M, Abruzzese E, Castagnetti F, Luciano L, Gozzini A, Annunziata M, Martino B, Stagno F, Cavazzini F, Tiribelli M, Visani G, Pregno P, Musto P, Fava C, Sgherza N, Albano F, Rosti G, Alimena G, Specchia G. Russo Rossi A, et al. Among authors: musto p. Haematologica. 2013 Mar;98(3):399-403. doi: 10.3324/haematol.2012.064337. Epub 2012 Jul 16. Haematologica. 2013. PMID: 22801965 Free PMC article.
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey.
D'Arena G, Laurenti L, Coscia M, Cortelezzi A, Chiarenza A, Pozzato G, Vigliotti ML, Nunziata G, Fragasso A, Villa MR, Grossi A, Selleri C, Deaglio S, La Sala A, Del Poeta G, Simeon V, Aliberti L, De Martino L, Giudice A, Musto P, De Feo V. D'Arena G, et al. Among authors: musto p. Leuk Lymphoma. 2014 Apr;55(4):841-7. doi: 10.3109/10428194.2013.803223. Epub 2013 Oct 17. Leuk Lymphoma. 2014. PMID: 23829282
More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection.
D'Arena G, Guariglia R, Pietrantuono G, Villani O, Martorelli MC, Mansueto G, Criscuolo C, Pierri T, Musto C, Musto P. D'Arena G, et al. Among authors: musto c, musto p. Leuk Lymphoma. 2014 Aug;55(8):1955-7. doi: 10.3109/10428194.2013.858151. Epub 2014 Feb 14. Leuk Lymphoma. 2014. PMID: 24152050 No abstract available.
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients.
D'Arena G, Simeon V, Laurenti L, Cimminiello M, Innocenti I, Gilio M, Padula A, Vigliotti ML, De Lorenzo S, Loseto G, Passarelli A, Di Minno MND, Tucci M, De Feo V, D'Auria F, Silvestris F, Di Minno G, Musto P. D'Arena G, et al. Among authors: musto p. Leuk Lymphoma. 2017 Nov;58(11):2633-2641. doi: 10.1080/10428194.2017.1306648. Epub 2017 Apr 3. Leuk Lymphoma. 2017. PMID: 28367662
Oxidative stress in chronic lymphocytic leukemia: still a matter of debate.
D'Arena G, Seneca E, Migliaccio I, De Feo V, Giudice A, La Rocca F, Capunzo M, Calapai G, Festa A, Caraglia M, Musto P, Iorio EL, Ruggieri V. D'Arena G, et al. Among authors: musto p. Leuk Lymphoma. 2019 Apr;60(4):867-875. doi: 10.1080/10428194.2018.1509317. Epub 2018 Sep 20. Leuk Lymphoma. 2019. PMID: 30234409 Review.
Superiority of Droplet Digital PCR Over Real-Time Quantitative PCR for JAK2 V617F Allele Mutational Burden Assessment in Myeloproliferative Neoplasms: A Retrospective Study.
La Rocca F, Grieco V, Ruggieri V, Zifarone E, Villani O, Zoppoli P, Russi S, Laurino S, Falco G, Calice G, Marinaccio A, Natalicchio MI, Albano F, Musto P. La Rocca F, et al. Among authors: musto p. Diagnostics (Basel). 2020 Mar 5;10(3):143. doi: 10.3390/diagnostics10030143. Diagnostics (Basel). 2020. PMID: 32150880 Free PMC article.
Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment.
Piccolomo A, Schifone CP, Strafella V, Specchia G, Musto P, Albano F. Piccolomo A, et al. Among authors: musto p. Cancers (Basel). 2020 Sep 5;12(9):2528. doi: 10.3390/cancers12092528. Cancers (Basel). 2020. PMID: 32899586 Free PMC article. Review.
Epitranscriptomics in Normal and Malignant Hematopoiesis.
Minervini CF, Parciante E, Impera L, Anelli L, Zagaria A, Specchia G, Musto P, Albano F. Minervini CF, et al. Among authors: musto p. Int J Mol Sci. 2020 Sep 9;21(18):6578. doi: 10.3390/ijms21186578. Int J Mol Sci. 2020. PMID: 32916783 Free PMC article. Review.
The Role of Autoimmune Diseases in the Prognosis of Lymphoma.
Masciopinto P, Dell'Olio G, De Robertis R, Specchia G, Musto P, Albano F. Masciopinto P, et al. Among authors: musto p. J Clin Med. 2020 Oct 23;9(11):3403. doi: 10.3390/jcm9113403. J Clin Med. 2020. PMID: 33114226 Free PMC article. Review.
625 results